Hear the MELODY The MELODY study will involve 36,000 immunocompromised people across the UK, starting with those with kidney and other organ transplants. The study will later include people with cancer and autoimmune diseases. Immunocompromised people tend to be less likely to develop an antibody response after vaccination. Using an